Exchange: NASDAQ Sector: Financial Services Industry: Marketing Services
-19.23% $8.44
America/New_York / 25 okt 2021 @ 00:00
FUNDAMENTALS | |
---|---|
MarketCap: | 425.36 mill |
EPS: | 0 |
P/E: | 0 |
Earnings Date: | N/A |
SharesOutstanding: | 50.40 mill |
Avg Daily Volume: | 2.27 mill |
RATING 2022-02-09 |
---|
B+ |
Buy |
RATINGS | ||
---|---|---|
Rating CashFlow: | Strong Buy | |
Return On Equity: | Neutral | |
Return On Asset: | Neutral | |
DE: | Neutral | |
P/E: | Strong Sell | |
Price To Book: | Strong Buy |
QUARTER GROWTHS | ||
---|---|---|
4/20 | 2/21 | |
Revenue | n/a | n/a |
Gr.Profit | n/a | n/a |
Ebit | n/a | n/a |
Asset | n/a | |
Debt | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE 0 | sector: PE -18.15 |
PE RATIO: COMPANY / INDUSTRY |
---|
N/A |
Company: PE 0 | industry: PE 0 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 8.41 - 8.47 ( +/- 0.37%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-01-11 | Martin James Joseph | Buy | 0 | |
2016-12-27 | Merriman D Jonathan | Buy | 100 000 | Common Stock, par value $0.0001 per share |
2015-04-10 | Merriman D Jonathan | Buy | 1 000 000 | Options (Right to Buy) |
2014-12-18 | Merriman D Jonathan | Sell | 375 000 | Options (Right to Buy) |
2014-12-18 | Merriman D Jonathan | Sell | 0 | Common Stock, par value $0.0001 per share |
INSIDER POWER |
---|
0.00 |
Last 4 transactions |
Buy: 1 100 000 | Sell: 375 000 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $8.44 (-19.23% ) |
Volume | 15.34 mill |
Avg. Vol. | 2.27 mill |
% of Avg. Vol | 676.28 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Big Cypress Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It intends to focus on life science companies in the United States and Israel. The company was founded in 2020 and is based in Miami Beach, Florida.